Acrivon Therapeutics, Common Stock Price on September 25, 2024
| ACRV Stock | 6.71 0.02 0.30% |
If you're considering investing in Acrivon Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acrivon Therapeutics, stands at 6.71, as last reported on the 23rd of December, with the highest price reaching 7.18 and the lowest price hitting 6.51 during the day. Acrivon Therapeutics, secures Sharpe Ratio (or Efficiency) of -0.0097, which signifies that the company had a -0.0097% return per unit of risk over the last 3 months. Acrivon Therapeutics, Common exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Acrivon Therapeutics,'s Standard Deviation of 3.74, mean deviation of 2.52, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
At this time, Acrivon Therapeutics,'s Common Stock Shares Outstanding is fairly stable compared to the past year. Stock Based Compensation is likely to climb to about 12.2 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 71.3 M in 2024. . At this time, Acrivon Therapeutics,'s Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to climb to 0.94 in 2024, whereas Price Earnings To Growth Ratio is likely to drop (0.02) in 2024. Acrivon Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acrivon |
Sharpe Ratio = -0.0097
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ACRV |
Estimated Market Risk
| 3.77 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Acrivon Therapeutics, is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acrivon Therapeutics, by adding Acrivon Therapeutics, to a well-diversified portfolio.
Price Book 1.0768 | Book Value 5.381 | Enterprise Value 28.6 M | Enterprise Value Ebitda (0.43) | Shares Float 11.2 M |
Related Headline
Sana Biotechnology Headline on 25th of September 2024
Disposition of 150000 shares by Richard Mulligan of Sana Bio... by Richard Mulligan
Filed transaction by Sana Biotechnology Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Acrivon Therapeutics, Valuation on September 25, 2024
It is possible to determine the worth of Acrivon Therapeutics, on a given historical date. On September 25, 2024 Acrivon was worth 7.2 at the beginning of the trading date compared to the closed value of 7.17. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acrivon Therapeutics, stock. Still, in general, we apply an absolute valuation method to find Acrivon Therapeutics,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acrivon Therapeutics, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acrivon Therapeutics,'s related companies.
| Open | High | Low | Close | Volume | |
| 7.28 | 7.31 | 7.00 | 7.19 | 52,666 | |
09/25/2024 | 7.20 | 7.24 | 7.03 | 7.17 | 40,200 |
| 7.26 | 7.55 | 7.06 | 7.26 | 84,853 |
| Backtest Acrivon Therapeutics, | | | Acrivon Therapeutics, History | | | Acrivon Therapeutics, Valuation | Previous | Next |
Acrivon Therapeutics, Trading Date Momentum on September 25, 2024
| On September 26 2024 Acrivon Therapeutics, Common was traded for 7.26 at the closing time. The top price for the day was 7.55 and the lowest listed price was 7.06 . The trading volume for the day was 84.9 K. The trading history from September 26, 2024 was a factor to the next trading day price increase. The overall trading delta against the next closing price was 1.26% . The overall trading delta against the current closing price is 1.53% . |
Acrivon Therapeutics, Fundamentals Correlations and Trends
By evaluating Acrivon Therapeutics,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acrivon Therapeutics,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acrivon financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acrivon Therapeutics, Stock history
Acrivon Therapeutics, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acrivon is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acrivon Therapeutics, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acrivon Therapeutics, stock prices may prove useful in developing a viable investing in Acrivon Therapeutics,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 22.1 M | 23.6 M | |
| Net Loss | -28.1 M | -29.5 M |
Acrivon Therapeutics, Quarterly Net Working Capital |
|
Acrivon Therapeutics, Stock Technical Analysis
Acrivon Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Acrivon Therapeutics, Period Price Range
Low | December 23, 2024
| High |
0.00 | 0.00 |
Acrivon Therapeutics, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acrivon Therapeutics, December 23, 2024 Market Strength
Market strength indicators help investors to evaluate how Acrivon Therapeutics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acrivon Therapeutics, shares will generate the highest return on investment. By undertsting and applying Acrivon Therapeutics, stock market strength indicators, traders can identify Acrivon Therapeutics, Common entry and exit signals to maximize returns
Acrivon Therapeutics, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acrivon Therapeutics,'s price direction in advance. Along with the technical and fundamental analysis of Acrivon Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acrivon to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.16) | |||
| Total Risk Alpha | (0.23) | |||
| Treynor Ratio | (0.08) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Acrivon Stock Analysis
When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.